[1]
“A review on Pharmacovigilance and drug safety post-marketing surveillance: https://doi.org/10.55522/ijti.v3i2.0112”, IJTI, vol. 3, no. 2, Feb. 2025, doi: 10.55522/ijti.v3i2.0112.